| |
|
|
|
Pluristem Therapeutics Inc.  
|
|
4.34 -0.02 (-0%) |
09-16 12:01 |
|
Open: |
4.36 |
Pre close: |
4.36 |
Target:
|
5.42 
|
|
High: |
4.43 |
Low: |
4.34 |
Resistance:
|
4.64
5.42
|
|
Volume: |
20,193 |
Market Cap: |
66M |
Support:
|
3.77
3.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.22
 |
MACD |
MACD(12,26):
|
0.22 |
|
MA(20): |
3.91 |
Signal(12,26,9): |
0.22 |
|
MA(100): |
1.95 |
Stochastic Oscillator |
%K(14,3):
|
83.60 |
|
MA(250): |
1.39 |
%D(3): |
80.50 |
|
Average Volume(K) |
3-Month: |
28832
|
52-Week |
High:
|
5.93 |
|
10-Days: |
5583 |
Low: |
0.40 |
|
RSI |
RSI(14):
|
62.72 |
Change(%): |
237.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.192 |
Return on Equity (ttm) |
-174.6 |
Shares Out. (M) |
15.31 |
|
EPS Est. Current Year |
-0.350 |
Return on Assets (ttm) |
-73.7 |
Shares Float (M) |
13.98 |
|
EPS Est. Next Year |
-0.340 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.43 |
|
EPS Est. Next Quarter |
-0.090 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
4.33 |
|
Forward EPS |
-0.350 |
Gross Profit (p.s.) |
0.003 |
Shares Short (K) |
135 |
|
Book Value (p.s.) |
0.720 |
EBITDA (p.s.) |
-2.246 |
P/E |
-1.36 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.04 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-28.57 |
P/S |
0.00 |
|
Operating Margin |
-67364.81 |
Levered Free Cash Flow
(M) |
-15.64 |
P/CF |
-2.33 |
|
|
|
|
|
|
